LPL Financial’s Pacific Biosciences PACB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$219K Sell
176,542
-7,261
-4% -$9K ﹤0.01% 4887
2025
Q1
$217K Sell
183,803
-1,419
-0.8% -$1.67K ﹤0.01% 4689
2024
Q4
$339K Sell
185,222
-10,291
-5% -$18.8K ﹤0.01% 4324
2024
Q3
$332K Sell
195,513
-5,929
-3% -$10.1K ﹤0.01% 4261
2024
Q2
$276K Buy
201,442
+20,790
+12% +$28.5K ﹤0.01% 4258
2024
Q1
$677K Buy
180,652
+477
+0.3% +$1.79K ﹤0.01% 3476
2023
Q4
$1.77M Buy
180,175
+4,844
+3% +$47.5K ﹤0.01% 2504
2023
Q3
$1.46M Buy
175,331
+20,386
+13% +$170K ﹤0.01% 2567
2023
Q2
$2.06M Sell
154,945
-5,557
-3% -$73.9K ﹤0.01% 2213
2023
Q1
$1.86M Sell
160,502
-44,664
-22% -$517K ﹤0.01% 2202
2022
Q4
$1.68M Sell
205,166
-8,766
-4% -$71.7K ﹤0.01% 2204
2022
Q3
$1.24M Buy
213,932
+12,447
+6% +$72.3K ﹤0.01% 2361
2022
Q2
$891K Buy
201,485
+70,255
+54% +$311K ﹤0.01% 2657
2022
Q1
$1.19M Buy
131,230
+30,597
+30% +$278K ﹤0.01% 2455
2021
Q4
$2.06M Buy
100,633
+21,035
+26% +$430K ﹤0.01% 2061
2021
Q3
$2.03M Buy
79,598
+178
+0.2% +$4.55K ﹤0.01% 2017
2021
Q2
$2.78M Buy
79,420
+35,812
+82% +$1.25M ﹤0.01% 1730
2021
Q1
$1.45M Sell
43,608
-87
-0.2% -$2.9K ﹤0.01% 2081
2020
Q4
$1.13M Buy
43,695
+20,985
+92% +$544K ﹤0.01% 2080
2020
Q3
$224K Buy
22,710
+3,085
+16% +$30.4K ﹤0.01% 3105
2020
Q2
$68K Buy
+19,625
New +$68K ﹤0.01% 3301
2019
Q3
Sell
-28,350
Closed -$172K 3340
2019
Q2
$172K Buy
28,350
+8,000
+39% +$48.5K ﹤0.01% 3048
2019
Q1
$147K Buy
+20,350
New +$147K ﹤0.01% 3000
2018
Q4
Sell
-23,095
Closed -$125K 3178
2018
Q3
$125K Buy
23,095
+2,405
+12% +$13K ﹤0.01% 3082
2018
Q2
$73K Buy
+20,690
New +$73K ﹤0.01% 3106
2017
Q4
Sell
-40,350
Closed -$212K 3037
2017
Q3
$212K Buy
40,350
+2,750
+7% +$14.4K ﹤0.01% 2618
2017
Q2
$134K Buy
+37,600
New +$134K ﹤0.01% 2672
2017
Q1
Sell
-11,450
Closed -$50K 2771
2016
Q4
$50K Hold
11,450
﹤0.01% 2638
2016
Q3
$101K Buy
+11,450
New +$101K ﹤0.01% 2530